http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0315188-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d15a4a3ede0e6e55194a1679d68c89e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e87f29e0db9416800cab4f60f6c468
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-546
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
filingDate 2003-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_743f7658106a8d0056cb6276a11aaf4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a28ce8d71cf809ca359c1381e7eaf3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_774e8703da9974518b0a1b77c8680e84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fa295854ccc0790657c8f8bf6f06afd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01f2bc4c7c026f61b3fe030609d28a2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4d118553f079fa0bc1ed954762ee57d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_359b7388360a0ec22cf6ab15676955db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e98daaf5abfa48932d5233e835cfa971
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b55cedbbd2a0d9e0cc12e5717ed9a87e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2839ce2f43f51a270642147ef1f2aa8e
publicationDate 2005-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0315188-A
titleOfInvention Headache Compound
abstract "CEFEM COMPOUNDS". The present invention relates to a compound of the formula [I]: where R3 is lower alkyl, hydroxy (lower) alkyl or halo (lower) alkyl, and R2 is hydrogen or amino protecting group, or R 13 and R 12 are linked together and form lower alkylene or lower alkenylene; R3 is hydrogen or lower alkyl; R4 is R5 is carboxy or protected carboxy; and R6 is a protected amino or amino, or a pharmaceutically acceptable salt thereof, a process for preparing a compound of formula [I], and a pharmaceutical composition comprising a compound of formula [I] in admixture with a pharmaceutically acceptable conductor. .
priorityDate 2002-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401

Total number of triples: 32.